Patients with CD4+ T cell counts <200 cells/mm3 and CD4+ T cell percentages <14% should receive chemoprophylaxis against PJP with one double-strength TMP-SMX tablet daily [12]. This evidence concerns the gene CD4 and pneumocystosis.